MedTrace Logo

Does a Novel Needle Over Catheter Device Improve First Pass Success and Decrease Complications

NCT06547294 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-02-12

No results posted yet for this study

Summary

Emergency Department Patients who were to get intravenous (IV) access through routine medical care will receive it through trademarked catheter via convenience sample. Patient and clinician experience, including adverse events, will be recorded. A standardized data entry sheet will be collected at time of enrollment, and then daily thereafter while the subject has the IV. The data collected will remain anonymous.

Conditions

  • Vascular Access Device Complications
  • Catheterization, Peripheral

Interventions

DEVICE

Osprey IV

Utilization of novel needle over catheter commercial insertion device

OTHER

Historical Controls

Outcome rates from catheter over needle devices (traditional manner of inserting peripheral IV)

Sponsors & Collaborators

  • Community Medical Center, Toms River, NJ

    lead OTHER

Principal Investigators

  • Gerado Chiricolo, MD · Robert Wood Johnson Barnabas Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2025-04-30
Completion
2025-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06547294 on ClinicalTrials.gov